{"id":1018228,"date":"2026-11-06T05:53:18","date_gmt":"2026-11-06T10:53:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"modified":"2026-11-06T05:53:18","modified_gmt":"2026-11-06T10:53:18","slug":"fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","title":{"rendered":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">RESEARCH TRIANGLE PARK, N.C., Nov.  06, 2026  (GLOBE NEWSWIRE) &#8212; Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2026 financial results before the opening of the U.S. financial markets on Thursday, November 12, 2026. Management will host a conference call and webcast that day to discuss the Company\u2019s financial and business results.<\/p>\n<p align=\"justify\">\n        <strong>Conference Call &amp; Webcast Detail:<\/strong>\n      <\/p>\n<p>\n        <strong>Date:<\/strong>\u00a0Thursday, November 12, 2026<br \/><strong>Time:<\/strong>\u00a08:30 a.m. Eastern Time<br \/><strong>Webcast Link: <\/strong><a href=\"https:\/\/edge.media-server.com\/mmc\/p\/vuhn59ek\" rel=\"nofollow\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/vuhn59ek<\/a><br \/><strong>Participant Link: <\/strong>https:\/\/register-conf.media-server.com\/register\/BIa5435e66b82346329a08be7e156e3eac<\/p>\n<p align=\"justify\">To access the live webcast link, log onto <a href=\"http:\/\/www.fennecpharma.com\" rel=\"nofollow\" target=\"_blank\">www.fennecpharma.com<\/a> and proceed to the News &amp; Events\/Event Calendar page under the Investors &amp; Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. A webcast replay of the conference call will also be archived on www.fennecpharma.com for thirty days.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Fennec Pharmaceuticals<\/strong><br \/>\n        <br \/>Fennec Pharmaceuticals Inc.\u00a0is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK<sup>\u00ae<\/sup>\u00a0to reduce the risk of platinum-induced ototoxicity in cancer patients. PEDMARK received FDA approval in\u00a0September 2022\u00a0and\u00a0European Commission\u00a0approval in\u00a0June 2023\u00a0and\u00a0United Kingdom\u00a0(U.K.) approval in\u00a0October 2023\u00a0under the brand name PEDMARQSI.<\/p>\n<p align=\"justify\">In\u00a0March 2024, Fennec entered into an exclusive licensing agreement under which\u00a0Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, will commercialize\u00a0PEDMARQSI<sup>\u00ae<\/sup>\u00a0in\u00a0Europe,\u00a0U.K.,\u00a0Australia\u00a0and\u00a0New Zealand. PEDMARQSI is now commercially available in multiple countries.<\/p>\n<p align=\"justify\">PEDMARK has received Orphan Drug Exclusivity in the\u00a0U.S.\u00a0and.; PEDMARQSI has received Pediatric Use Marketing Authorization in\u00a0Europe, which includes eight years plus two years of data and market protection. Further, Fennec has patents providing protection for PEDMARK until 2039 in both the\u00a0U.S.\u00a0and internationally.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"http:\/\/www.fennecpharma.com\/\" rel=\"nofollow\" target=\"_blank\">www.fennecpharma.com<\/a>\u00a0and follow on\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/fennecpharma\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Robert Andrade<br \/>Chief Financial Officer<br \/>Fennec Pharmaceuticals Inc.<br \/>+1 919-246-5299<\/p>\n<p>\n        <strong>Corporate and Media:<\/strong><br \/>\n        <br \/>Lindsay Rocco <br \/>Elixir Health Public Relations<br \/>+1 862-596-1304<br \/><a href=\"mailto:lrocco@elixirhealthpr.com\" rel=\"nofollow\" target=\"_blank\">lrocco@elixirhealthpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NGU1NWM5YzEtYjNjMi00MTg4LWIxY2UtNzJjYTViY2VmYzc2LTExMDE0MjItMjAyNi0xMS0wNi1lbg==\/tiny\/Fennec-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2026 financial results before the opening of the U.S. financial markets on Thursday, November 12, 2026. Management will host a conference call and webcast that day to discuss the Company\u2019s financial and business results. Conference Call &amp; Webcast Detail: Date:\u00a0Thursday, November 12, 2026Time:\u00a08:30 a.m. Eastern TimeWebcast Link: https:\/\/edge.media-server.com\/mmc\/p\/vuhn59ekParticipant Link: https:\/\/register-conf.media-server.com\/register\/BIa5435e66b82346329a08be7e156e3eac To access the live webcast link, log onto www.fennecpharma.com and proceed to the News &amp; Events\/Event Calendar page under the Investors &amp; Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1018228","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2026 financial results before the opening of the U.S. financial markets on Thursday, November 12, 2026. Management will host a conference call and webcast that day to discuss the Company\u2019s financial and business results. Conference Call &amp; Webcast Detail: Date:\u00a0Thursday, November 12, 2026Time:\u00a08:30 a.m. Eastern TimeWebcast Link: https:\/\/edge.media-server.com\/mmc\/p\/vuhn59ekParticipant Link: https:\/\/register-conf.media-server.com\/register\/BIa5435e66b82346329a08be7e156e3eac To access the live webcast link, log onto www.fennecpharma.com and proceed to the News &amp; Events\/Event Calendar page under the Investors &amp; Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the &hellip; Continue reading &quot;Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-06T10:53:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026\",\"datePublished\":\"2026-11-06T10:53:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"wordCount\":384,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"name\":\"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\",\"datePublished\":\"2026-11-06T10:53:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk","og_description":"RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its third quarter 2026 financial results before the opening of the U.S. financial markets on Thursday, November 12, 2026. Management will host a conference call and webcast that day to discuss the Company\u2019s financial and business results. Conference Call &amp; Webcast Detail: Date:\u00a0Thursday, November 12, 2026Time:\u00a08:30 a.m. Eastern TimeWebcast Link: https:\/\/edge.media-server.com\/mmc\/p\/vuhn59ekParticipant Link: https:\/\/register-conf.media-server.com\/register\/BIa5435e66b82346329a08be7e156e3eac To access the live webcast link, log onto www.fennecpharma.com and proceed to the News &amp; Events\/Event Calendar page under the Investors &amp; Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the &hellip; Continue reading \"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-06T10:53:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026","datePublished":"2026-11-06T10:53:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"wordCount":384,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","name":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=","datePublished":"2026-11-06T10:53:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyMCM3OTUwMjM4IzIwODk4NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fennec-pharmaceuticals-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on\u00a0November 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1018228"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018228\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1018228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1018228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1018228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}